Showing results (11-20 of 57) with videos related to
Sort By:
Pageof 6
International Journal of Molecular Sciences|July 26, 2018
Binding of Organometallic Ruthenium Anticancer Complexes to DNA: Thermodynamic Base and Sequence SelectivitySuyan Liu, Aihua Liang, Kui Wu, et al.Clinical Breast Cancer|September 7, 2025
Mendelian Randomization Study: The Impact of Gut Microbiota on Survival in HR+ Breast Cancer Patients Under Different Treatment Regimens Through the Modulation of Immune Cell PhenotypesCongting Hu, Jia Liu, Suyan Liu, et al.Scientific Reports|August 6, 2020
Porcine reproductive and respiratory syndrome virus infection induces endoplasmic reticulum stress, facilitates virus replication, and contributes to autophagy and apoptosisQuangang Chen, Yanjuan Men, Dang Wang, et al.Dalton Transactions (Cambridge, England : 2003)|June 25, 2015
Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligandsYang Zhang, Wei Zheng, Qun Luo, et al.The Analyst|July 17, 2014
Identification and discrimination of binding sites of an organoruthenium anticancer complex to single-stranded oligonucleotides by mass spectrometrySuyan Liu, Kui Wu, Wei Zheng, et al.Chinese Journal of Natural Medicines|March 4, 2026
Natural resources, chemical synthesis, chemo-bio transformations, metabolism, pharmacology, toxicology, and the underlying mechanisms of curdioneSuyan Liu, Jiayin Han, Yushi Zhang, et al.Veterinary Microbiology|June 1, 2010
The genomic diversity of Chinese porcine reproductive and respiratory syndrome virus isolates from 1996 to 2009Bin Li, Liurong Fang, Suyan Liu, et al.Breast (Edinburgh, Scotland)|February 15, 2024
Is circulating tumor cell count-driven cost-effective for first-line therapy choice in HR+/HER2- metastatic breast cancer in the United States?Huiting Lin, Wenhua Wu, Xiaoya Lou, et al.Emerging Infectious Diseases|December 8, 2009
Recombination in vaccine and circulating strains of porcine reproductive and respiratory syndrome virusesBin Li, Liurong Fang, Zuofei Xu, et al.Cellular Oncology (Dordrecht, Netherlands)|October 6, 2025
TAK-981 potentiates doxorubicin immunocide in triple-negative breast cancer by IFN I-dependent NK cell stimulationJia Liu, Yiming Wang, Xiaoxia Wei, et al.Pageof 6